Aldo-keto Reductase Family 1 Member C3 (AKR1C3) Is a Biomarker and Therapeutic Target for Castration-Resistant Prostate Cancer

Overview of attention for article published in Molecular Medicine, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Method for determining risks associated with hormone-dependent cancers

N/A SE-2250144-A1

Sweden

AKR1C3 INHIBITOR AND MEDICAL USE

Application WO-2021000862-A1

World Intellectual Property Organisation (WIPO)

DNA ALKYLATING AGENTS FOR USE IN THE TREATMENT OF CANCER

Application EP-3747508-A1

European Patent Office

[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones

Application US-10167293-B2

United States of America

Processes for the preparation of dehydroepiandrosterone and its intermediates

Application US-9879045-B2

United States of America